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Dosage compensation, mediated by the MSL com-
plex, regulates X-chromosomal gene expression in
Drosophila. Here we report that the histone H4 lysine
16 (H4K16) specific histone acetyltransferase MOF
displays differential binding behavior depending on
whether the target gene is located on the X chromo-
some versus the autosomes. More specifically, on
the male X chromosome, where MSL1 and MSL3
are preferentially associated with the 30 end of dos-
age compensated genes, MOF displays a bimodal
distribution binding to promoters and the 30 ends of
genes. In contrast, on MSL1/MSL3 independent
X-linked genes and autosomal genes inmales and fe-
males, MOF binds primarily to promoters. Binding
of MOF to autosomes is functional, as H4K16 acety-
lation and the transcription levels of a number of
genes are affected upon MOF depletion. Therefore,
MOF is not only involved in the onset of dosage
compensation, but also acts as a regulator of gene
expression in the Drosophila genome.
INTRODUCTION
Genetic material does not exist freely in the cell but is in complex
with histone proteins to form chromatin. Histones are subject to
a wide variety of posttranslational modifications that impose
changes on chromatin structure. Among the various histone
modifications, acetylation is one of the best studied (for reviews
see (Kurdistani and Grunstein, 2003; Lee and Workman, 2007;
Yang and Seto, 2007). X-chromosomal dosage compensation
in Drosophila melanogaster is a model system that is used to
gain better understanding of broad chromosome-wide transcrip-
tional regulation by hyperacetylation (for reviews see Lucchesi
et al., 2005;MendjanandAkhtar, 2006;StraubandBecker, 2007).
Dosage compensation is a process that balances the expres-
sion of sex-linked genes in species that have evolved unequal
numbers of sex chromosomes. InDrosophila this involves hyper-activation of the single male X chromosome to equalize for the
combined transcriptional activity of both female X chromo-
somes. This process is regulated by the MSL complex, which
consists of at least five male-specific lethal proteins (MSL1,
MSL2, MSL3, maleless [MLE], and males-absent-on-the-first
[MOF]) and two noncoding RNAs (roX1 and roX2) (for review
see Straub and Becker, 2007).
Although the individual components of the MSL complex have
been studied extensively, the molecular mechanisms underlying
the process of dosage compensation remain poorly character-
ized. MSLs are thought to function, in part, in the recruitment
and activation of MOF at the X chromosome. MOF is a histone
acetyl transferase (HAT) that specifically acetylates lysine 16 of
histone H4 (H4K16Ac), a modification found highly enriched on
the male X chromosome (Akhtar and Becker, 2000; Bone et al.,
1994; Hilfiker et al., 1997; Smith et al., 2000).
The role of H4K16Ac in transcriptional regulation is not com-
pletely understood. DrosophilaMOF protein targeted to a heter-
ologous promoter by the GAL4 DNA-binding domain releases
chromatin-mediated transcriptional repression by H4K16Ac in
yeast (Akhtar and Becker, 2000) and causes chromatin decon-
densation on the male X chromosome in Drosophila (Corona
et al., 2002). Although H4K16Ac does not correlate with active
genes in yeast (Kurdistani et al., 2004), it is specifically associ-
atedwith the activity of a subset of genes, whereas all other acet-
ylation marks on histone H4 exhibit an additive effect (Dion et al.,
2005). H4K16Ac modifications pose a structural constraint on
higher-order chromatin formation; it is therefore possible that
maintenance of transcriptional potential could be one of its func-
tions. In this role, H4K16Acwould serve to limit the association of
repressive protein complexes and, in tandem, relax the chroma-
tin fiber to permit accessibility of the transcriptional machinery
(Shogren-Knaak et al., 2006). At present, the distribution of
H4K16Ac across the length of gene loci, together with its pre-
sumed role in chromatin decondensation, has given rise to the
hypothesis that the MSL complex is involved in transcriptional
elongation (Smith et al., 2001).
Although MSLs are mainly studied in Drosophila, all MSL pro-
teins have conserved orthologs in mammals (Marin, 2003). This
implies functional conservation in species with radically different
dosage compensation mechanisms. Not only do the humanCell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 813
814 Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc.
MSLs (hMSL) form a complex like in Drosophila, most of their
interaction partners are also conserved (Mendjan et al., 2006;
Smith et al., 2005; Taipale et al., 2005). Furthermore, MOF in
Drosophila is the only MSL protein to bind all chromosomes
independently of the MSL complex in both males and females
(Bhadra et al., 1999). These properties, together with evidence
of evolutionary conservation, suggest a role for both MOF and
H4K16Ac in transcriptional regulation beyond the process of
dosage compensation.
To gain insight into the role of MOF in the regulation of gene
expression, we performed a comprehensive genome-wide anal-
ysis of MOF/MSL-bound DNA by a series of chromatin immuno-
precipitations directed against specific MSL proteins, followed
by hybridization to high-resolution tiling arrays (the ChIP-chip
method; see Horak and Snyder, 2002). This strategy allowed
us to generate binding profiles for MSL1, MSL3, and MOF, along
with H4K16 acetylation, in ‘‘male’’ Schneider (SL-2) cells as well
as MOF and H4K16Ac in ‘‘female’’ Kc cells (see below). These
analyses were complemented with microarray-based gene ex-
pression profiles of SL-2 cells depleted of MSL1, MSL3, and
MOF, and of MOF-depleted Kc cells.
Our data reveal MOF as a transcriptional regulator, not only on
the X chromosome but also on autosomes. Intriguingly, MOF on
the X chromosome associates with promoters and the 30 end of
genes, whereas on autosomes and the female genome MOF as-
sociates primarily with promoters. Furthermore, an accumulation
ofH4K16Acmarks isobservedoverentiregene loci on theXchro-
mosome, whereby this pattern is a direct reflection of MOF activ-
ity,whileonautosomes,acetylationwas found topeak toward the
50 end of target genes. Interestingly, we found that binding to 30
ends of genes by MSL1, MSL3, and MOF is interdependent on
the X chromosome; however, MOF association to promoter-
proximal regions was found to be independent of MSL1, similar
to the binding site distribution across the autosomes. It therefore
appears that the role of the MSL complex members is to recruit
MOF toward the gene interior, allowing more extended acetyla-
tion toward the 30 end. These results provide interesting insights
into the mechanism of MSL complex recruitment on dosage-
compensated genes and reveal an unprecedented role of MOF
on autosomes independent of the MSL complex.
RESULTS
Correlated MSL Binding and H4K16 Acetylation
on the Male X Chromosome
We created high-resolution (35 bp) genome-wide DNA-binding
profiles of MSL1, MSL3, MOF, and H4K16Ac in Drosophila
Schneider SL-2 cells using the ChIP-chip method to hybridize
chromatin-immonuprecipitated DNA to Affymetrix tiling arrays.To equalize for the level of histones, control ChIP samples
were isolated using a histone H4 specific antibody. ChIP DNA
samples were produced and hybridized as three independent
biological replicates, which showed highly reproducible binding
profiles (Figures S1 and S2). To facilitate unbiased comparisons
across different ChIP-chip experiments, we considered the top-
most one percent of enriched binding-site loci scored for each
condition (see Experimental Procedures).
The use of genome-wide tiling arrays makes it possible to
study the localization of MSL1, MSL3, MOF, and H4K16Ac sites
systematically, on all chromosomes and at high resolution. To
elucidate the properties of DNA association independently of
dosage compensation, we analyzed binding-site occupancy of
each protein over the X chromosome and the autosomes in par-
allel. Chromatin profiling of MSL1,MSL3,MOF, as well as H4K16
acetylation exhibited a high degree of coincidence across the X
chromosome (Figure 1A). As expected, we observed a clear
preference for MSL1, MSL3, and MOF to bind the X chromo-
some rather than autosomes (Figure S3). Further analysis re-
vealed that 534 X-chromosomal genes were bound by the three
MSL proteins (Figure 1B).
To further assess the accuracy of our approach, we examined
a large (150 kb) region of the X chromosome for binding of
MSL1 and MOF with three independent chromatin samples
followed by quantitative real-time PCR (qRT-PCR). In addition,
primers were designed to amplify the roX2 and runt genes; these
serve as positive and negative controls, respectively, and have
been used routinely for this purpose in other studies of the
MSL complex (Kind and Akhtar, 2007; Legube et al., 2006; Smith
et al., 2001). These qRT-PCR results correlate well with the
profiles generated by global ChIP-chip analyses (Figure S4).
MSL1 and MSL3 are bound to few autosomal genes, whereas
MOF displayed extensive binding to autosomes (Figures 1B, 1C,
and S5). Consistent with these observations, MOF was also
found to associate globally to autosomes on polytene chromo-
somes, albeit with a clearly lower incidence of binding than on
the X chromosome (Figure 1D). In contrast to MOF, only a small
number of sites could be observed for MSL3 on autosomes
(Figure 1D). We therefore conclude that in contrast to MSL1
and MSL3, which preferentially bind to the X chromosome,
MOF also binds extensively to autosomes.
MOF Displays a Bimodal Binding Pattern
on X-Chromosomal Genes
As demonstrated here, MSL1, MSL3, and MOF display a clear
preference for binding to loci across the X chromosome. Given
these results, we then examined individual gene components
to elucidate patterns of binding to coding sequences, introns,
and untranslated regions. Consistent with previous observationsFigure 1. High-Resolution Map of MSL1, MSL3, MOF, and H4K16Ac Chromatin Profiling in Drosophila SL-2 Cells
(A) MOF binds the X chromosome in association with the MSL complex, but binds independently to autosomes. Shown in (A) are topmost 1% ranked binding loci
of MSL1, MSL3, MOF, and H4K16Ac on a section of the X chromosome representing 1.5 Mb. Flybase (+) and () represents the location of genes on the forward
and reverse DNA strands, respectively. Coordinates represent the position on the corresponding chromosome.
(B) Overlap of MSL1, MSL3 and MOF target genes on the X chromosome and autosomes.
(C) Comparison of the distribution of MSL1, MSL3, and MOF binding on the chromosome arm 2L.
(D) Immunostaining of polytene chromosomes from male third instar larvae using antibodies against MOF (red) and MSL3 (green). DNA staining is shown in blue
(Hoechst 322).Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 815
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(Alekseyenko et al., 2006; Gilfillan et al., 2006; Legube et al.,
2006), MSL1, MSL3, and MOF bind preferentially to gene loci
over both intergenic regions and UTRs on the X chromosome
(Figure S6A–S6C). In striking contrast, however, a significant en-
richment of MOF binding sites to autosomal intergenic regions
and 50UTRs was observed, whereas binding to 30UTRs is nearly
absent (Figure S6C and S6E). This marked shift in binding pref-
erence suggests diversified functional association of MOF to
intragenic regions between the X chromosome and autosomes.
To establish an average binding profile across regulated gene
loci, oligonucleotide probe sets corresponding to bound genes
(on X chromosomes and autosomes) were analyzed for relative
binding frequency along the scaled lengths of gene loci (Figures
2A–2D and S7). In this manner, it can be seen that H4K16 acet-
ylation gradually increases toward the 30 ends of genes, similar to
the pattern displayed by MSL1 andMSL3. Surprisingly however,
MOF displays a bimodal pattern of binding toward the beginning
and the 30 end of genes (compare Figure 2C to Figures 2A, 2B,
and 2D). Similar results were obtained by performing the analy-
ses reporting only one significant bound probe per gene per
standardized region to account for gene length effects (data
not shown). Distribution of individual probe intensities across in-
dividual genes further confirmed that this bimodal binding of
MOF represent the bona fide behavior of MOF on individual
genes rather then a simple superimposition of two distinct
classes of sites on the X chromosome (Figures 2E and S8).
Complementary analyses of MOF binding at transcription start
and stop sites revealed that MOF binding peaks at promoter re-
gions, on autosomal and X chromosomal target genes. In addi-
tion, MOF binds along the body and 30 end of genes located
on the X chromosome (Figures S9 and S10). MOF is enriched
approximately 0–500 bp upstream of the transcription start
site, which we refer to hereafter as MOF promoter binding
(Figure S9). Intriguingly, the H4K16Ac profile across the X chro-
mosome is enriched toward the 30 ends of genes in a pattern very
similar to theMSL3 profile (compare Figure 2Bwith 2D). Intensity
of MOF binding at 30 end of X-linked genes was significantly
higher compared to the 50 ends (p <4e-08) (Figure S11A). In con-
trast, MOF binding on autosomes was significantly higher at 50
ends of autosomal genes (p 0.014) (Figure S11B).
It therefore appears evident that in SL-2 cells MOF binds to
promoters as well as throughout the body of X-chromosomal
genes, where binding peak at 30 ends. This is in contrast to the
activity observed on autosomes, where MOF binding peaks at
promoters.
MOF Binds Promoter-Proximal Regions in Kc Cells
Differential binding of MOF to X chromosomal genes and auto-
somes with respect to MSL1 and MSL3 in SL-2 cells (Figures2C and S7C) prompted us to perform genome-wide analysis of
MOF binding andH4K16Ac in Kc cells. In Kc cells, MSL2 is trans-
lationally repressed by SXL as part of the sex-determination
pathway (Bashaw and Baker, 1995; Zhou et al., 1995). Conse-
quently, the MSL complex cannot assemble, and its members
are unstable (Kelley et al., 1995). Kc cells may therefore be re-
garded as ‘‘female’’ cells as opposed to ‘‘male’’ SL-2 cells where
MSL complex members are expressed and exhibit the classical
staining pattern of the male X chromosome (Duncan et al., 2006;
Mendjan et al., 2006).
In contrast to the pattern of activity observed in SL-2 cells,
MOF binding sites and H4K16Ac marks are not restricted to
the X chromosome but rather are distributed evenly across the
genome in Kc cells (Figures S3, S6E, S6F and 3A). In addition,
MOF does not display a bimodal distribution across gene loci
in Kc cells, but instead is mainly restricted to promoters with
a concurrent shift in the H4K16Ac profile from 30 to 50 enrichment
(Figure S9). Notably, when in SL-2 cells the top-most-ranked 1%
significant autosomal gene targets were analyzed independently
of the X chromosome, the MOF and H4K16Ac profiles appear
nearly identical to those obtained from Kc cells (Figure 3B).
Furthermore, a significant number of genes are similarly
bound by MOF on autosomes in SL-2 and Kc cells (Figure 3C).
In keeping with these results, the binding-site occupancy is
nearly identical between both cell types (Figure S12). Interest-
ingly, we found that the intensity of 50 MOF binding was signifi-
cantly higher on the X chromosome versus autosomes in both
SL-2 cells (p < 2e-18) and Kc cells (p < 3e-08) (Figure S13). Fur-
thermore, MOF binding correlated highly significantly with
H4K16Ac occupancy in both SL-2 (p < 2.2e-16) and Kc cells
(p < 2.2e-16) (Figure 3D). We also found that approximately
80%of all MOF-bound targets (autosomes and X chromosomes)
are active genes in both SL-2 and Kc cells (Figure S14; see Sup-
plemental Experimental Procedures). Among the 1980 genes
bound byMOF in the two cell lines, Gene Ontology (GO) analysis
revealed a number of statistically overrepresented biological
processes related to the cell cycle (Figure S14C; Table S1). Sim-
ilarly, a variety of other biological processes were found to be
significant among genes bound independently in either SL-2
(971 genes) or Kc cells (943 genes). These results are summa-
rized in Tables S2 and S3.
Taken together these results demonstrate that MOF, in addi-
tion to binding across the body of genes on the male X chromo-
some, binds promoters of transcriptionally active genes in both
SL-2 and Kc cells on all chromosomes.
MOF Binding to Promoters Is Independent of MSL1
Global analyses in both cell types revealed that MOF resides on
promoters on all chromosomes (Figures 2 and 3). InvariantFigure 2. Bimodal Distribution of MOF on X-Chromosomal Genes
(A–D) Normalized binding distribution to gene loci in SL-2 cells using topmost1% targets. Distribution of MSL1, MSL3, andMOF and H4K16Ac across the X chro-
mosome. Genes with significant binding were scaled to similar lengths, and the relative position of significant probes was computed. Bars represent the number
of significant probes in a given region. A continuous fit of the distribution is depicted in red. MOF binds to promoters (50 ends) and toward the 30 ends of X-chro-
mosomal gene loci. This bimodal binding pattern is different from the primarily 30 enrichment of MSL1, MSL3, and H4K16Ac (A-D). TSS represents (transcription
start site) and END represents (transcription stop site).
(E) MSL1,MSL3, andMOF binding intensity on a single X-chromosomal target gene (PH1). Flybase (+) and () represents the location of genes on the forward and
reverse DNA strands respectively. Coordinates represent the position on the corresponding chromosome.Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 817
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binding of MOF to promoters of X-linked genes between SL-2
and Kc cells (Figure 3B) argues for MSL-independent targeting
of MOF to promoters on the X chromosome. To test this hypoth-
esis, we performed RNAi-mediated depletion of MSL1 followed
by ChIP-qRT-PCR analysis to study MOF recruitment. We ana-
lyzed the four X-linked genes CG8173, par-6, Ucp4a, and the
previously identified ‘‘high-affinity site’’ roX2, where MSL1 re-
cruitment has been shown to be MOF independent (Kelley
et al., 1999; Park et al., 2002). PCR primers were designed to
span the promoter (P1), middle (P2), and end (P3) of each gene
(See Experimental Procedures). In MSL1-depleted cells, binding
of MOF is severely compromised across the lengths of all four
genes tested as compared to the control EGFP RNAi-treated
cells, whereas MOF binding to promoter-proximal regions
remained unaffected (Figures 4A–4D).
Consistent with the ChIP-chip analysis, MOF was found to
bind promoters on the same set of genes in Kc cells, without
any substantial enrichment toward the interior of X chromo-
somal genes, with the exception of modest binding to the
roX2 high-affinity site (Figure S15A). The presence of MSL1
could not be detected above threshold levels on any of the
other X-chromosomal genes in Kc cells, in agreement with
polytene chromosome stainings (data not shown). Similarly,
MOF displayed sole promoter occupancy for an X-chro-
mosomal gene (CG12094) and three autosomal genes (hbs1,
frazzled [fra], gprk2) in SL-2 cells that were not found to be en-
riched by MSL1 or MSL3 (Figure S15B). We therefore conclude
that MOF recruitment to promoters is MSL-independent on
dosage-compensated genes in both SL-2 and Kc cells,
whereas MOF binding to the 30 ends of these genes requires
MSL1.
We have previously shown that sequences toward the 30 end
of two dosage-compensated genes contain targeting cues for
the MSL complex (Kind and Akhtar, 2007). We were therefore
interested in testing whether MSL1 and MSL3 target the 30
end of genes independently of MOF, and whether MOF localiza-
tion to the gene interior is MSL dependent. In agreement with
previous studies on polytene chromosomes, MSL1 binding to
roX2 is only mildly affected upon MOF depletion. Since roX2
is a high-affinity site where partial complexes containing
MSL1 can assemble independently of MOF and MSL3, this ex-
periment showed consistency with previously published data
(Kelley et al., 1999; Park et al., 2002) and confirmed the repro-
ducibility between both experiments (Figure 4H). However,
MSL1 binding to the three dosage-compensated genes or
low-affinity sites (Ucp4A, par-6, CG8173) is significantly re-
duced in cells depleted of MOF when compared to the EGFP
RNAi control samples (Figures 4E–4G). Therefore, we conclude
that MOF is essential for targeting of the MSL complex to
dosage-compensated genes or low-affinity binding sites. Incontrast, binding of MSL1 to high-affinity sites such as roX2 is
independent of MOF.
MOF Is Responsible for Bulk H4K16 Acetylation
Although MOF alone displays HAT activity in vitro (Akhtar and
Becker, 2000), this has been shown to be enhanced when
MOF is in complex with MSL1 and MSL3 (Morales et al., 2004).
The shift in H4K16Ac 30 enrichment on the X chromosome
(Figure 2D) to 50 enrichment on autosomes in SL-2 and Kc cells
(Figure 3B), together with the correlation between MOF binding
and H4K16Ac in both SL-2 and Kc cells (Figure 3D), suggests
that MOF is active as a HAT on promoters independently of the
MSL complex in vivo.
In order to test for HAT activity of MOF on promoters, we an-
alyzed H4K16Ac levels for a subset of X-chromosomal (CG8173,
par-6, Ucp4A, roX2) and autosomal (hbs1, fra, gprk2) genes by
ChIP-qRT-PCR analysis in cells depleted of MOF (Figure 5).
EGFP dsRNA-treated cells were used as controls. Control
ChIP for histone H4 levels was performed in parallel for each
condition. We were also eager to test whether the presence of
MOF at promoters of X-chromosomal genes in the absence of
MSL1 is sufficient for HAT activity. As shown in Figure 5, while
histone H4 levels remain unaffected (gray plots), we observe
that H4K16Ac on the target genes is markedly reduced upon
MOF depletion on both X-chromosomal and autosomal targets
compared to EGFP dsRNA-treated control cells (red plots).
H4K16Ac levels in MSL1-depleted cells were reduced only on
X-chromosomal genes, whereas in the case of autosomal MOF
targets, H4K16Ac levels remained unaffected or showed only
a slight increase. This could be due to an excess of available
MOF protein following its apparent dissociation from the X chro-
mosome (black plots). These results strongly suggest that MOF
is directly involved in H4K16 acetylation of its target genes and
that, in addition, MOF’s activity on the X chromosome is coordi-
nated by the other MSLs similar to the behavior observed in vitro
(Morales et al., 2004).
These observations were further confirmed by mass spectro-
metric analysis of endogenous histones isolated from control
EGFP- or MOF dsRNA-depleted SL-2 and Kc cells (Figure 6).
MOF levels were depleted to approximately 20% of those ob-
served in EGFP dsRNA-treated samples in SL-2 and Kc cells
(Figure 6A). Interestingly, we found that at steady state only
about 20% of histones were monoacetylated in SL-2 cells
and approximately 15% in Kc cells. Of this monoacteylation,
H4K16Ac was accounted for by approximately 29% and 23%
of total acetylation in SL-2 and Kc cells, respectively. Depletion
of MOF resulted in a clear reduction of lysine 16 acetylation,
such that overall monoacetylation levels dropped to approxi-
mately 11% in both cell lines. In contrast, monoacetylation at
H4K5 remained unaffected (Figure 6). Taken together, theseFigure 3. MOF Is Bound to Promoter-Proximal Regions on Autosomes in SL-2 and Kc Cells
(A) Binding profile of MOF and H4K16Ac in SL-2 and Kc cells on about 1 Megabase (MB) region of chromosome 2L. Flybase (+) and () represents the location of
genes on the forward and reverse DNA strands, respectively. Coordinates represent the position on the corresponding chromosome.
(B) Probe frequency and density measurements of MOF binding and H4K16Ac to gene loci on the autosomes in SL-2 and Kc cells. Default binding of MOF to
promoters in SL-2 and Kc cells results in a shift in the H4K16Ac pattern toward the 50 end across gene loci.
(C) Overlap in MOF target genes between SL-2 and Kc cells on autosomes.
(D) MOF binding significantly correlates with H4K16Ac in both SL-2 (p < 2e-16) and Kc cells (p < 2e-16).Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 819
Figure 4. Binding of MOF to Promoters Is Independent of MSL1
(A–H) MOF is essential for targeting of MSL1 and MSL3 to X-linked genes, but does not itself require MSL1 for binding to promoters. Chromatin immunoprecip-
itation (ChIP) using MSL1 (black), MOF (red), and MSL3 (gray) antibodies in MSL1 (A–D) or MOF-depleted (E–H) cells. Binding of MSL1 (black), MOF (red), and
MSL3 (gray) to the X-linked genes ucp4a, par-6,CG8173, rox2 is shown. EGFP dsRNA-treated cells were used as controls. ChIP is shown as percentage recovery
of input DNA. Primers were positioned at the promoter (P1), middle (P2), and end (P3) of genes. The exact position of the primers is described in the Supplemental
Data. ChIP is shown as percentage recovery of input DNA (% Input). Error bars represent standard deviation (StDev) of three independent experiments.820 Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc.
Figure 5. MOF Is Active as a Histone Acetyltransferase on Both the X Chromosome and Autosomes
Chromatin immunoprecipitation (ChIP) using histone H4 and H4K16Ac-specific antibodies on four X-linked genes ucp4a, par-6, CG8173, roX2, and three auto-
somal genes hbs1, fra, and gprk2 in MSL1- (black) and MOF-depleted (red) cells. Histone H4 ChIP (gray) remained mostly unaffected in both MSL1 and MOF
dsRNA-treated cells. Primers were positioned at the promoter (P1), middle (P2), and end (P3) of genes. Exact position of the primers is described in the Supple-
mental Data. ChIP is shown as percentage recovery of input DNA (% input). Error bars represent standard deviation (StDev) of three independent experiments.results show that MOF is responsible for the bulk of H4K16
acetylation events in both SL-2 and Kc cells.
Dosage Compensation Acts Mainly by Local Binding
of MSL Complexes
The correlation between MOF association and H4K16Ac in both
SL-2 and Kc cells (Figures 3D and 5) prompted us to test for the
transcriptional regulation of genes by MOF in both cell types by
RNAi-mediated depletion followed by hybridization of the la-
beled transcript population to Affymetrix Drosophila 2 gene ex-
pression arrays (see Experimental Procedures). In addition, we
also determined the expression profiles of SL-2 cells depleted
of MSL1 and MSL3, in order to compare between regulation
by MOF inside and outside the MSL context. All experiments
were performed in triplicate and normalized against control
EGFP dsRNA-treated samples. The three MSL proteins couldbe successfully depleted to a level between 10%–20%
compared to EGFP RNAi-treated cells (Figure S16).
Overall, MOF depletion resulted in themost significant number
of differentially expressed genes, followed byMSL3 andMSL1 in
SL-2 cells (Figures 7A–7D). MSL1 depletion results in downregu-
lation of primarily X-chromosomal genes. On the X chromosome,
almost all affected genes were found to be downregulated
(Figure 7D). Interestingly, where anMSL1 knockdown almost ex-
clusively affects X-chromosomal genes, MSL3 and MOF RNAi
treatment results in both up- and downregulation of autosomal
genes (Figures 7A–7D). Genes affected byMOF andMSL3 could
be subcategorized into various biological functions with certain
emphasis on cell cycle-related processes (Table S4). We next
tested whether genes that were only upregulated (252 genes)
or downregulated (217 genes) by MSL3 on autosomes were
associated with a particular biological process. However, ourCell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 821
Figure 6. Global Levels of H4K16Ac Are Affected upon MOF Depletion in Both SL-2 and Kc Cells
(A–C) Relative quantitative analysis of acetylation of histone H4 sites K5/K8/K12 and K16 by mass spectrometry. (A) shows western blot analysis of the efficiency
of MOF depletion in SL-2 (right panel) and Kc cells (left panel). Dilution of the corresponding extracts is indicated. (B) showsMonoacetylated peptides containing
the four acetylation sites (amino acid [aa] 4–17) in relation to nonacetylated peptide H4 in SL-2 (B) and Kc (C) cells. Columns 1 and 2, total amount of monoacety-
lated peptide as fraction of nonacetylated peptide population; Columns 3 and 4, K16-monoacetylated peptide as of fraction nonacetylated peptide population;
columns 5 and 6, K5-monoacetylated nonacetylated peptide population. MOF-directed dsRNA interference (MOF RNAi, gray columns) in SL-2 cells leads to
a reduction of the total fraction of monoacetylated peptide in comparison with an unrelated (EGFP RNAi, black columns) control. Site-specific analysis reveals
that H4K16 acetylation reflects loss of acetylation, while K5 acetylation remains unaffected. In contrast, in Kc cells overall monoacetylation seems to be only
slightly affected by dsRNA interference. Nevertheless, H4K16 site-specific monoacetylation is reduced by a factor of 2, indicating a significant contribution to822 Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc.
analysis did not reveal a particularly intriguing overrepresented
category (Tables S5 and S6).
The majority of genes downregulated on the X chromosome
are bound by MSL1, MSL3, or MOF (Figure 7E). We confirmed
this finding by ChIP with MOF and MSL1, followed by qRT-
PCR analysis of SL-2 cells depleted of these proteins for 18
genes in an approximately 150 kb region (see Figure S4). As
shown in Figure 7E, genes bound by MSL1 and MOF generally
show good correlation with differentially downregulated genes
in the cells depleted for MOF and MSL1 (compare upper and
lower panels of Figure 7F). The minority of genes that are differ-
entially expressed but not bound could be either secondary tar-
gets or genes distally regulated via long-range elements. We
conclude that, in general, genes on the X chromosome that are
subject to dosage compensation are directly bound by the
MSL complex in agreement with previous studies (Alekseyenko
et al., 2006; Gilfillan et al., 2006).
On autosomes, approximately 30% of the genes differentially
regulated in MOF-deprived cells are bound (Figure S17). In Kc
cells, we observed that a similar number of downregulated
genes were bound by MOF but only 15% of the upregulated
genes comprise real targets (Figure S17). We verified gene reg-
ulation by MOF of three target genes (hbs1, fra, gprk2) shown to
display reduced H4K16Ac levels upon MOF depletion (Figure 5).
We could confirm that for all three genes expression levels
were reduced approximately 2-fold (Figure S18). Interestingly,
although MSL1 depletion showed no effect on hbs1 and fra,
expression of gprk2 was reduced similar to a MOF knockdown,
indicating that in exceptional cases MSL1 is involved in the reg-
ulation of some genes on the autosomes. Taken together, these
findings further support a role for MOF in the regulation of
expression of genes on the X chromosome and a subset of auto-
somal genes.
DISCUSSION
Differential Distribution of the MSL Complex Members
on Target Genes
Consistent with previousMSL1 andMSL3 profiling studies (Alek-
seyenko et al., 2006; Gilfillan et al., 2006; Legube et al., 2006), we
show that MSL1, MSL3, MOF, and H4K16Ac display enrichment
to 30 end of genes in SL-2 cells. Surprisingly, MOF displays a bi-
modal binding pattern on genes residing on the X chromosome,
associatingwith both the 30 ends of dosage-compensated genes
as well as with promoter regions.
Our recent observations on individual X-chromosomal target
genes using transgene analysis in vivo have revealed that there
are at least two classes of sites; transcription-independent
‘‘high-affinity sites’’ such as roX2 and transcription-dependent
‘‘low-affinity sites’’ such as mof or CG3016 (Kind and Akhtar,
2007). Integrating the observations obtained from the genome-
wide binding and RNAi-mediated knockdown analysis shown
here, it appears that MOF plays a central role in targeting the
MSL complex to ‘‘low-affinity sites’’ where recruitment of
MSL1 and MSL3 is found to be dependent on the presence ofMOF. This is in contrast to the ‘‘high-affinity sites’’ where partial
complexes of MSL1/MSL2 can be recruited independently of
MOF, MSL3, and MLE (Dahlsveen et al., 2006).
Interestingly, we found that MOF binds not only to the male X
chromosome, but also to autosomes and female chromosomes
(Figure S3). Different from the bimodal binding pattern of MOF on
the male X chromosome, in Kc cells, MOF is enriched to pro-
moters of all chromosomes similarly to the situation on the
male autosomes in SL-2 cells (Figures 3B and S10). However, al-
though the binding pattern between the X and the autosomes in
Kc cells looks practically identical, the amplitude of promoter
binding is significantly higher on the X chromosome than on
the autosomes in Kc cells, as is the case in SL-2 cells
(Figure S13). It is possible that X-chromosomal genes have as-
yet-unidentified sequence elements that contribute toward
MOF binding to promoters of X-chromosomal genes in males
and females. Alternatively, since reduced amount of MSL1 is
expressed in females (Kelley et al., 1995) and MSL1 displays
low-level promoter binding on the X chromosome in SL-2 cells,
it may contribute to higher amplitude of MOF binding on
X chromosomal genes in both SL-2 and Kc cells compared to
autosomes (Figures 2A, 2E, and S8). As the gene density on
the X chromosome is similar to that of other chromosomes (ex-
cept for the fourth chromosome), this does not explain the higher
amplitude of MOF binding on the X chromosome. It is therefore
possible that MOF, in addition to its role in facilitating transcrip-
tional elongation by acetylating gene loci in an MSL context, is
also involved in transcriptional initiation in an MSL-independent
manner, perhaps by interaction with additional factors. Another
interesting possibility is that the enrichment ofMOF to promoters
may provide a reservoir of enzyme, held in check by other
factors, to be readily used by the MSL proteins or other pro-
moter-bound complexes when needed for modulating transcrip-
tion levels.
Intriguingly, the MSL3 profile across gene loci appeared very
similar to that of H4K16Ac (Figures 2A–2D), suggesting a role
for MSL3 in activation and/or stabilization of H4K16Ac on
X-linked genes. In support of this hypothesis, MSL3 has been
shown to stimulate MOF’s HAT activity in vitro (Morales et al.,
2004). Recently, MSL3 was shown to bind H3K36 trimethylated
(H3K36me3) nucleosomes, and H3K36me3 (which also peaks at
30 end of genes, similar to MSLs) was shown to influence MSL
binding (Bell et al., 2008; Larschan et al., 2007). In S. cerevisiae,
Eaf3 recognition of H3K36me3 has been shown to direct
Rpd3(S) to actively transcribed genes to deacetylate histones
in the wake of polymerase II, preventing spurious transcription
within genes from cryptic promoters (Carrozza et al., 2005). It
has been proposed that theMSL complex on the X chromosome
may compete for the Rpd3(S) complex, thereby increasing the
overall H4K16Ac levels by reducing the turnover rates of this
modification (Larschan et al., 2007).
As the 30 ends of genes are indispensable for MSL target
recognition on the X chromosome (Kind and Akhtar, 2007), we
propose that MSL1 and MSL2 initially target 30 regions by
occasional recognition of degenerative DNA target elementsH4K16 acetylation byMOF-dependent activity in Kc cells. Error bars represent standard error of mean (SEM) of at least three independent experiments. See also
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(Dahlsveen et al., 2006; Gilfillan et al., 2006; Kind and Akhtar,
2007), possibly made accessible by low levels of H4K16Ac
brought about by MOF occupancy of the promoter. MSL3 may
serve to stabilize the association of MSL1/MSL2 with dosage-
compensated genes by binding to H3K36me3, which in turn
may lead to the recruitment and stimulation of MOF to the
body of the gene. It has also been proposed that local recycling
of RNA polymerase II could result in enhancedmRNA production
(Schubeler, 2006; Smith et al., 2001). MOF, with its enrichment to
promoter-proximal and 30 regions, is a likely candidate to bridge
such a loop formation. Gene structural studies should reveal
whether such a gene-loop formation is involved in the process
of dosage compensation.
MOF, H4K16 Acetylation, and Gene Regulation
Here we present four independent lines of evidence that show
that MOF is involved in H4K16Ac of a large number of genes in
the male and female genome. A: MOF binding significantly cor-
relates with H4K16Ac of all chromosomes in both SL-2 and Kc
cells (Figure 3D). B: The H4K16Ac profile across genes corre-
lates strongly with the diversified binding of MOF between the
X chromosome (peaking toward the 30 end of genes), and auto-
somes (peaking toward the 50 end of genes [compare Figures
2C–2D with 3B]). C: Depletion of MOF results in a marked de-
crease in H4K16Ac of a number of genes on both the X chromo-
some and the autosomes (Figure 5). D: In MOF-depleted SL-2
and Kc cells we find a more than 50% reduction in total
H4K16Ac levels by mass specterometery analysis (Figure 6).
Several studies have implied a structural role for histone acet-
ylation and H4K16Ac acetylation in particular, in the packaging
of DNA into chromatin. Interestingly, H4K16Ac has been shown
to cause an increase in the a-helical content of histone H4, and to
prevent 30 nm chromatin-fiber formation and crossfiber interac-
tions (Shogren-Knaak et al., 2006). H4K16Ac might therefore
serve a structural role, imparting a relaxed chromatin state
that, in turn, reduces the energy required for RNA polymerase
II to affect transcription through a nucleosomal template and
thereby enhancing elongation efficiency (Calestagne-Morelli
and Ausio, 2006).
Regulation of ubiquitously expressed (housekeeping) genes
on the X chromosome by the MSL complex (Legube et al.,2006; Gilfillan et al., 2006) probably necessitates a state of con-
tinual association with its target binding sites. Elevated levels of
H4K16Ac are reached on the X chromosome presumably by
constant activation of MOF by MSL1 and MSL3. On the auto-
somes, since MOF appears to be present independently of other
MSL proteins, it does not associate to the interior of gene loci
but is instead promoter bound, similar to its behavior on the
X chromosome in the MSL1-depleted condition (Figure 4).
Assuming that MOF is involved in general transcription regula-
tion, apart from dosage compensation, it is not surprising that
MOF is required for most H4K16 acetylation (Figure 6). Similarly,
MOF in mammals has been found to be responsible for most, if
not all, H4K16Ac (Smith et al., 2005; Taipale et al., 2005). Inter-
estingly, in line with a possible role for MOF in the G2/M cell-cy-
cle checkpoint in mammals (Taipale et al., 2005) we found that in
both SL-2 and Kc cells, MOF-bound targets are significantly en-
riched for certain cell-cycle functional categories (Tables S1, S2,
and S3). It would therefore be very interesting to study gene
regulation by MOF in a cell-cycle context in synchronized cells.
The role of MOF mediated H4K16Ac on the autosomes re-
mains speculative. H4K16Ac modification on autosomes by
MOF may create an opportunity for transcription initiation/reini-
tiation, rather than being an essential mark for transcriptional ac-
tivity itself (Anguita et al., 2001). This could also explain why we
observe that, although MOF is generally bound to active genes
(Figure S14), approximately 30% of the autosomal bound genes
are affected by MOF depletion (Figure S17). MOF’s presence on
autosomal genes may therefore provide a minimal landscape of
H4K16Ac, maintaining a local environment with relatively open
chromatin structure, presumably similar to the condition of
mating type loci in yeast (Johnson et al., 1990; Megee et al.,
1990). Upon transcriptional cues, those genes would be able
to rapidly and efficiently respond tomeet the cell’s requirements,
as would be the case for cell cycle-related genes (as discussed
above).
Second, MOFmay work together with as-yet-uncharacterized
proteins, which may allow RNA polymerase II to move efficiently
through the chromatin template similar to the situation on the X
chromosome. In fully elucidating the molecular mechanisms be-
hind this process, a vital step will be the characterization of ad-
ditional protein complexes associated with MOF, apart fromFigure 7. Dosage Compensation Acts by Upregulation of the X Chromosome on a Gene-by-Gene Basis
(A–C) Genome distribution of differentially expressed genes inMSL1-, MSL3-, andMOF-depleted SL-2 cells. Downregulated genes (green lines) and upregulated
genes (red lines) are shown. The white areas on the chromosomes indicate the position of genes.
(D) Venn diagram representing overlap of up- or downregulated genes on the X chromosome or autosomes.
(E) Correlation between differential expression and MSL1, MSL3, and MOF binding on the X chromosome in SL-2 cells. Each major column represents genes
significantly downregulated in the MSL1, MSL3, and MOF RNAi depletion assays, respectively (note that each group of columns represent different numbers
of genes, as shown in D). Within each group, the proportion of genes bound by MSL1, MSL3, and MOF in the ChIP-chip experiments is shaded in blue (minor
columns). Genes were sorted by hierarchical clustering within each group. Unbound genes are represented as white sections. y axis represents the proportion of
the total number of downregulated genes on the X chromosome.
(F) Correlation between binding (top) and expression (bottom) of 18 genes on the X chromosome by qRT-PCR. MOF is depicted in red and MSL1 is shown in
black. Error bars represent standard deviation (StDev) of three independent experiments for both ChIP and expression analysis.
(G) Workingmodel for MOF recruitment on X-linked and autosomal genes. Our data suggest that MOF is recruited to promoter-proximal regions independently of
MSL1 and MSL3. In the context of the X chromosome, the concerted action of other complex members, such as MSL1 and MSL3, allows recruitment of MOF
throughout gene loci, resulting in more extended acetylation over intragenic regions peaking toward the 30 end. In contrast, on autosomes H4K16 acetylation
marks are most abundant toward the 50 ends of genes, directly reflecting the distribution of MOF binding sites. A broader distribution of MOF protein on X-linked
genes, together with an extendedH4K16 acetylation, may therefore confer efficient transcriptional elongation. While on autosomes, 50-end acetylationmay affect
a poised state of transcriptional potential, facilitatingmore effective transcription factor binding and/or promoting transcription initiation. H4K16Ac is represented
as red asterisks.Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc. 825
the MSL complex (Dou et al., 2005; Mendjan et al., 2006; Smith
et al., 2005). We propose that such complexes, comprising
different trans-activating or repressive factors, may modulate
MOF’s HAT activity resulting in differential transcriptional out-
puts. Furthermore, MOFbinding to promotersmay allow efficient
and rapid response to cellular events by recruitment/exclusion of
H4K16 binding proteins or, more generally, by unique H4K16Ac-
induced conformational changes to the chromatin fiber. Interest-
ingly, one of the evolutionary conserved interacting partners of
MOF is WDS, a protein in mammals shown to associate with
histone H3 lysine 4 methylation, a histone mark enriched at
promoters (Dou et al., 2005; Han et al., 2006; Mendjan et al.,
2006; Wysocka et al., 2005). It would be interesting to study
the potential involvement of WDS or other promoter-bound
factors in recruiting MOF to promoters.
In summary, this study has revealed that the MSL complex
members do not conform to a uniform binding behavior on their
target genes on the X chromosome, MSL1 and MSL3 are en-
riched at the 30 end of genes, while MOF shows a bimodal distri-
bution with enrichment at promoter-proximal regions as well as
30 ends. Our data reveal that MOF plays a central role in the tar-
geting process on low-affinity sites where recruitment of MSL1
and MSL3 appear to be dependent on the presence of MOF, in
contrast to high-affinity sites such as roX2 where targeting of
MSL1 appears to be MOF independent. Furthermore, the previ-
ously unappreciated binding of MOF to promoter-proximal re-
gions on X-chromosomal as well as autosomal sites provides
an opportunity to investigate additional roles of this enzyme in
other cellular processes.
EXPERIMENTAL PROCEDURES
Chromatin immunoprecipitation (ChIP)
All ChIP experiments were performed at least three times using independent
chromatin preparations. The antibodies for MSL1, MSL3, and MOF are as de-
scribed in Mendjan et al. (2006). Anti-H4K16Ac (ab23352) and anti-Histone H4
(ab10158) rabbit polyclonal antibodies are from Abcam. SL-2 cells were grown
in Schneider medium (GIBCO) containing 10% FCS. 13 108 cells were cross-
linked with formaldehyde for 8 min. Sonication was performed for 263 30 s at
input 5 (Bioruptor, Diagenode) in lysis buffer (50 mM HEPES/KOH at pH 7.5,
500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS + Com-
plete protease inhibitors [Roche]). One hundred micrograms of chromatin and
three microliters of polyclonal antibody was used per IP. Immunocomplexes
were isolated by adding protein A/G-Sepharose (Roche) followed by four
washing steps: 2x lysis buffer, 1x DOC buffer (10 mM Tris at pH 8, 0.25 M
LiCl, 0.5%NP-40, 0.5%DOC, 1mMEDTA), and 1x TE at pH 8. DNAwas eluted
in 1X elution buffer (1% SDS, 0.1 M NaHCO3) for 20 min RT followed by rever-
sal of crosslinks at 65CO/N. DNA was purified by a 30 min incubation at 37C
RNaseA (0.2 mg/ml), followed by 2 hr Proteinase K digestion (0.05 mg/ml),
phenol/chlororform exctraction, and DNA precipitation. ChIP DNA samples
were resuspended in 100 ml TE. We used 1 ml ChIP material for each Q-PCR
reaction.
Processing and Hybridization of ChIP DNA
Processing of the ChIP DNA samples for hybridization was performed accord-
ing to Legube et al. (2006). Hybridization, washing, and scanning of arrays
followed the Affymetrix ChIP-chip protocols.
ChIP-Chip and Expression Data Analyses and Availability
Details on ChIP-chip and gene expression data analyses are available as
Supplemental Experimental Procedures.826 Cell 133, 813–828, May 30, 2008 ª2008 Elsevier Inc.RNA Interference (RNAi)
RNAi of SL-2 and Kc cells was performed as described in (Worby et al., 2001)
with the following modifications. All knockdowns cells were incubated with
45 mg dsRNA. The cells were harvested after 4 days for MSL1 RNAi and 7
days for MSL3 and MOF RNAi. For both time points, GFP control RNAi exper-
iments were performed in parallel.
Quantitative Real-Time PCR
qRT-PCR analysis of the ChIP samples was performed using the SYBR Green
PCR master mix (Applied Biosystem), 100 ng of each forward and reverse
primer, and 1 ml immunoprecipitated DNA, in an ABI7500 real-time PCR ther-
mocycler (Applied Biosystems, Inc.). The formula [% ChIP/input] =
[E(Ctinput
Ct
ChIP
) * 100%] (where E represents primer annealing efficiency)
was used to calculate the percentage DNA recovery after ChIP as compared
to the amount of input material. For quantitation of transcript levels, RNA was
first reverse transcribed using the SuperScript RT (Invitrogen), and 500 ng
random hexamers. One microliter of cDNA was then subjected to real-
time PCR using the SYBR Green PCR master mix (Applied Biosystems) and
100 ng of each primer. The primers designed in the middle of the genes in
the ChIP experiment were used for the analysis of the transcript levels.
Immunostaining of Polytene Chromosomes
Preparation of polytene chromosomeswasperformed as described (http://www.
igh.cnrs.fr/equip/cavalli/Lab%20Protocols/Immunostaining.pdf). Rat MSL3 and
rabbit MOF antibodies were used at 1:500 dilution. Images were captured
with an AxioCamHRCCD camera on a Zeiss Axiovert 200 Mmicroscope using
a 100x PlanApochomat NA 1.4 oil immersion objective.
ACCESSION NUMBERS
Microarray data are available in the ArrayExpress database (Parkinson et al.,
2007) under accession numbers E-MEXP-1508 (ChIP-chip records) and
E-MEXP-1505 (gene expression records).
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Supplemental Data include 18 figures, 6 tables, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
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